CCN1 and neoplasm: Additionally, among others, the chemokine CX3CL1 (32), TLR-agonists like Resiquimod (R484) (29), CYR61/CCN1 (30), TNF-α (28), oxidized LDL (31) and tumor cells (27) were reported to alter the kinetics of the patrolling behavior.